We further assessed FBXO44 expression across a panel of CRC cell lines and observed that both protein and mRNA levels in NCM460 cells were significantly lower than in the tumor cell lines (Figure 1J,K). The gene discussed is FBXO44; the disease is colorectal carcinoma.